go back

Vermont rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Professionalmedian $562,341 · 10th–90th $562,341–$588,8440%50%90th$562,341$100.0K$200.0K$500.0K$1.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $588,843.66
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$61,659.50 / $630,957.34 / $891,250.94